Clinical Trials Directory

Trials / Unknown

UnknownNCT05155267

Biomonitoring of Internal Exposure to MNPLs, and Its Effects, in Blood of Patients With Chronic Kidney Disease (CKD)

Biomonitoring of Internal Exposure to MNPLs (Micro and NanoPlastics), and Its Effects, in Blood of Patients With Chronic Kidney Disease (CKD)

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Ricard Marcos · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

Micro and nanoplastics (MNPLs) effects on human heath is still preliminary. Chronic kidney disease (CKD) participants, specially does patients submitted to hemodialysis, are a population high exposed to plastics. The objective of our research is to be able to detect MNPLs on biological fluids of hemodialysis patients as well as their potential genotoxic and immunological damage.

Detailed description

The exponential increase in the production/use of plastic translates into a parallel increase of environmental plastic-waste that is continuously degraded into micro and nanoplastics (MNPLs). Information on the MNPLs' effects on human health is still preliminary and, furthermore, the limitations in current methodologies prevent accurate human exposure/risk assessment. The study aims to analyse specific biomarkers of exposure to MNPLs in humans, as well as biomarkers of genetic damage, which will allow an association between exposure to these plastic materials and the optimisation of different techniques for the detection and characterisation of MNPLs. The study will evaluate the effect of exposure to MNPLs, analysing the genotoxic damage, different biomarkers of exposure and the effects on microbiota, in different body samples (urine, blood and feces).

Conditions

Interventions

TypeNameDescription
OTHERBiomonitoring study to detect MNPLs in biological samples and study of their health effectsDetermination of MNPLs levels, genotoxic damage and immunological effects

Timeline

Start date
2024-02-27
Primary completion
2024-12-01
Completion
2025-01-01
First posted
2021-12-13
Last updated
2024-03-18

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05155267. Inclusion in this directory is not an endorsement.